Fierce Pharma names Dr. Sangeeta Bhatia as one of the most influential people in biopharma

(By Eric Sagonowsky, Annalee Armstrong, Max Bayer, Angus Liu, Fierce Pharma) As the biopharma industry develops increasingly specialized treatments, regulators are being forced to adapt. And at the same time, the industry is making strides toward becoming more inclusive.

For the final chapter of the 2022 Most Influential People in Biopharma special report, Fierce Pharma is highlighting industry leaders who are blazing a path on both fronts. They're experts who are reshaping cancer drug development or reimbursement dynamics, plus an advocate who is fostering a community for LGBTQ+ people in the industry. The FDA's returning commissioner is featured because his agency faces a host of pressing issues in 2022. And Fierce Pharma is highlighting the work of an advocate who's helping place women in leadership roles in the industry. Read more…

Previous
Previous

MIT faculty tackle big ideas in a symposium kicking off Inauguration Day

Next
Next

The Marble Center Announces the Winners of this Year’s Poster Symposium